The use of platelet glycoprotein IIb/IIIa receptor antagonists during the acute phase of myocardial infarction.
van den Brand
M
M
Department of Interventional Cardiology, Thoraxcenter, University Hospital Dijkzigt, Dr. Molewaterplein 40, Rotterdam, PB 2040, 3000 CA, The Netherlands. sadi@card.azr.nl
Ronner
E F
EF
D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D002986:Clinical Trials as Topic; D003326:Coronary Circulation / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D015912:Thrombolytic Therapy / Q000379:methods
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex